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Introduction: Clinically in ventricular ﬁbrillation (VF), ECG amplitude, and frequency
decrease as ischemia progresses and predict deﬁbrillation success. In vitro ECG amplitude
declines without ischemia, independent of VF frequencies.This study examines the contri-
bution of cellular electrical activity and global organization to ECG amplitude changes during
VF. Methods and Results: Rabbit hearts were Langendorff-perfused (40mL/min, Tyrode’s
solution) and loaded with RH237. During VF, ECG, and epicardial optical action potentials
were recorded (photodiode array; 256 sites, 15mm× 15mm). After 60 s of VF, perfusion
was either maintained, global ischemia produced by low-ﬂow (6mL/min), or solution [K+]o
raised to 8mM. Peak-to-peak amplitude was determined for all signals. During VF, in con-
trol, ECG amplitude decreased to a steady-state (∼57% baseline), whereas in low-ﬂow
steady-state was not reached with the amplitude continuing to fall to 33% of baseline by
600 s. Optically, LV amplitude declinedmore than RV, reaching signiﬁcance in control (LV vs.
RV; 33± 5 vs. 63± 8%, p< 0.01). During VF in 8mM [K+]o, amplitude changes were more
complex; ECG amplitude increased with time (105± 13%), whilst LV amplitude decreased
(60± 15%, p< 0.001). Microelectrode studies showed amplitude reduction in control and
8mM [K+]o (to∼79 and∼93% baseline, respectively). Evaluation of electrical coordination
by cross-correlation of optical signals showed as VF progressed coordination reduced in
control (baseline 0.36± 0.02 to 0.28± 0.003, p< 0.01), maintained in low-ﬂow (0.41± 0.03
to 0.37± 0.005, p =NS) and increased in 8mM [K+]o (0.36± 0.02 to 0.53± 0.08, p< 0.05).
Conclusion: ECG amplitude decline in VF is due to a combination of decreased systolic
activation at the cellular level and increased desynchronization of inter-cellular electrical
activity.
Keywords: ECG, optical mapping, floating microelectrode, ischemia, ventricular fibrillation
INTRODUCTION
Ventricular ﬁbrillation (VF) is the major cause of sudden death
in the western world; the annual incidence of out-of-hospital VF
arrests in USA is ∼50,000 with a median survival to discharge of
only 6.4% (Nichol et al., 1999). The rate of successful resuscita-
tion in these arrests diminishes with time and is associated with
a reduction in the frequency and amplitude of the oscillations of
the surface ECG (Stewart et al., 1992; Callaway and Menegazzi,
2005). Indeed many clinical (Weaver et al., 1985; Strohmenger
et al., 1997, 2001; Eftestol et al., 2004) and animal (Noc et al., 1994;
Achleitner et al., 2000, 2001; Kolarova et al., 2003) studies have
shown that the amplitude of ECG oscillation in VF just prior to
deﬁbrillation can predict the likelihood of deﬁbrillation success
and may be the most useful ECG parameter to assess optimal tim-
ing of deﬁbrillation in out-of-hospital arrests (Strohmenger et al.,
2001).
Although many of these studies have correlated the reduction
in amplitude with factors such as delay to instigation of cardiopul-
monary life support (Weaver et al., 1985) or the degree of coronary
perfusion (Noc et al., 1994; Achleitner et al., 2000), the underlying
cause of the reduction in ECG amplitude is unknown. Model-
ing studies show that VF becomes increasingly disorganized with
time (Plank et al., 2005) and this in itself could result in reduction
of amplitude in global electrical assessments such as the ECG as
the incoherent electrical vectors cancel each other. In comparison,
transmembrane recordings in single cell studies show reduction
in amplitude of action potentials in ischemic conditions (Tissier
et al., 2002). Therefore the aim of this study was to evaluate the
various contributions of reduced coordination and cellular elec-
trical activity to the reduction in amplitude of the global ECG
amplitude changes in VF.
MATERIALS AND METHODS
LANGENDORFF PERFUSION
New Zealand White rabbits (adult male weighing 3–3.5 kg)
were sacriﬁced by intravenous injection of 0.5ml/kg Euthatal
(sodium pentobarbitone 200mg/kg, Rhône Mérieux) with 500 IU
of heparin. All procedures were approved by the local ethical com-
mittee (University of Glasgow) and complied with Home Ofﬁce
(UK) regulations. Hearts were rapidly excised, then Langendorff-
perfused at constant rate of 40ml/min with Tyrode’s solution at
37˚C [composition (mM):Na 134.5,Mg 1.0,K 5.0,Ca 1.9,Cl 101.8,
SO4 1.0, H2PO4 0.7, HCO3 20, acetate 20, glucose 50, and pH 7.4
(95% O2/5% CO2)].
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OPTICAL MAPPING
Hearts were placed into a custom-made Plexiglas cham-
ber (Figure 1A) which allowed control of bathing solution
temperature, and recording of global ECG from ﬁxed electrodes.
Optical mapping was performed as previously published (Cald-
well et al., 2007). Brieﬂy, hearts were loaded with 100μL of RH237
(Molecular Probes), dissolved in DMSO (1mg/ml). No excitation-
contraction uncoupler was used in VF experiments. Hearts were
brieﬂy immobilized mechanically for optical recordings. Light at
535± 25nm (interference ﬁlter, Comar Instruments Ltd,UK) illu-
minated the anterior surface of the heart. Fluorescent light was
focused at ×1.2 magniﬁcation onto a 16× 16 photodiode array
(C4675-102,HamamatsuPhotonicsUKLtd) after passing through
a 695 nm long-pass ﬁlter. Each photodiode detected light from
0.8mm× 0.8mm area of epicardium with the full array recording
from a ∼15mm× 15mm area. Digitized data (1 kHz) was stored
and analyzed ofﬂine using locally developed software written in
Delphi (Borland Software Corp, CA, USA).
After initial loading of voltage-sensitive dye, emission ﬂuo-
rescence can be affected by factors other than the membrane
potential, including dye concentration (i.e., washout), internaliza-
tion to the inner leaﬂet of the cell membrane and photobleaching
(Salama, 2001). A progressive change in any of these factors could
result in optical amplitude decline. Assuming that these changes
occurred equivalently in sinus rhythm and VF the effect of these
uncontrollable factors on the spontaneous degradation in the opti-
cal amplitudewas investigated in preparations inwhichVFwas not
induced. In these experiments, 3μM cytochalasin D was adminis-
tered to reduce motion artifact as previously described (Caldwell
et al., 2007). This allowed accurate measurement of AP amplitude
during atrial pacing.
FLOATING MICROELECTRODE
As previously described, a number of hearts were prepared for
ﬂoatingmicroelectrode impalement (Caldwell et al., 2007). Brieﬂy,
after insertion of an LV balloon, hearts were placed in a cham-
ber adapted for microelectrode impalement of the LV epicardium
by boring a 5mm diameter hole in the Plexiglas front-plate.
The chamber was rotated 90˚ to allow impalement of the epi-
cardium with vertical microelectrodes suspended in an adjustable
clamp. Microelectrodes of borosilicate glass (WPI, Sarasota, FL,
USA) were pulled using a P-97 Flaming/Browning pipette puller
(Sutter Instruments, Novato, CA, USA) and ﬁlled with 2M KCl
before the tips were mounted onto silver chloride coated sil-
ver wire (total resistance 20–25MΩ). Transmembrane potentials
[recorded via Microprobe Model 750 (WPI, Sarasota, FL, USA)]
were taken during RV pacing with a cycle length (CL) of 180ms
and VF (Figure 1D). This allowed measurement of the resting
membrane potential, or the maximum negative potential in VF
(diastolic potential), and the maximum positive potential (systolic
potential). Signals were also analyzed in the frequency domain.
VF PROTOCOL AND ANALYSIS
Using platinum hook electrodes placed in the posterior aspect
of the RV, VF was induced by burst pacing (50Hz stimula-
tion for 8 s). In all protocols hearts were perfused with nor-
mal Tyrode’s solution at 40ml/min for the ﬁrst 60 s of VF.
FIGURE 1 | (A) Langendorff-perfused rabbit heart in optical mapping
chamber. The superimposed grid represents the area of the myocardium
(16×16 pixel) visualized by the photodiode array. (B) ECG recording during
(i) ventricular ﬁbrillation (VF), and (ii) VF with peaks identiﬁed (red
asterisks). (C) Optical pixel recordings from LV epicardium during (i) in VF,
and (ii) in VF with peaks identiﬁed (red asterisks). (D)Transmembrane
recordings of the LV epicardium during (i) in VF, and (ii) VF with systolic and
diastolic peaks identiﬁed.
Perfusion was maintained at 40ml/min during control proto-
cols, whereas in experimental protocols, either the perfusion rate
(global ischemia – 6ml/min) or solution composition was altered
([K+]o = 8mM) at 60 s; raised [K+]o = 8mM was chosen as
this best reproduced the frequency changes observed in low-ﬂow
ischemia in our previous work (Caldwell et al., 2007). Solution
change in both the perfusate and the chamber was completed by
90 s. In optical mapping experiments, ECG and optical record-
ings were taken for 4 s periods, ECGs were recorded every 30 s
(Figure 1B) and optical measurements every minute (Figure 1C).
In microelectrode experiments fresh impalements were achieved
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approximately every 30 s (Figure 1D). As impalement was lost the
resting membrane potential started to depolarize. Care was taken
only to analyze stable impalements.
As previously published (Caldwell et al., 2007), frequencypower
spectra were derived for all ECG, optical and microelectrode sig-
nals recorded duringVF using Fast Fourier Transform. From these
power spectra, the dominant frequency (DF) was identiﬁed as the
frequencywith the greatest power between 3 and 50Hz. The power
spectra of all pixelswere summed toproduce a global optical power
spectra which is commonly known as the pseudoECG (psECG;
Chen et al., 2000). The peak-to-peak amplitude was determined
using locally developed software in all ECG, optical, and micro-
electrode signals recorded during VF. This software ﬁrst ﬁltered
the raw signal by third-order polynomial subtraction, high pass
(50Hz), and low pass (3Hz) ﬁlters. As shown in Figure 1B–D, the
VF extrema were then identiﬁed.
CROSS-CORRELATION
Optical resolution with the 256 pixel PDA is insufﬁcient to allow
accurate determination of activation sequences and identiﬁcation
of point singularities which requires the higher resolution of CCD
cameras. Hence we determined the coordination of the optical sig-
nals across the optical ﬁeld using a technique described by Choi
et al. (2003). As shown in Figure 2 the coordination of optical
signals during VF was assessed by calculating the correlation coef-
ﬁcient betweenpairs of signals after shifting one signal by a variable
time lag. The correlation coefﬁcient between normalized signals
from two pixels was calculated as a function of the lag time and
the maximum correlation coefﬁcient (CCmax) determined. The
processwas repeated for all pairs of pixels and themean correlation
coefﬁcient calculated for the whole ﬁeld.
STATISTICAL ANALYSIS
Data are expressed as mean± SEM. Signiﬁcance testing with
repeated ANOVA and paired t -test were performed using Instat3
(GraphPad Software Inc., USA). For ECG, optical signal and
microelectrode amplitude data were compared between (i) imme-
diately after VF induction and (ii) the time interval of 420–540 s.
Spatiotemporal changes were assessed at 480 s representing the
mid-point of this time period.
RESULTS
VF AMPLITUDE IN CONTROL CONDITIONS
As shown in Figure 3A, in VF during control conditions
(40ml/min, n = 7), the ECG amplitude reduced over the ﬁrst
240 s, after this there was no signiﬁcant change in amplitude with
a more“steady-state”with a reduction to∼55% of baseline ampli-
tude. The simultaneous optical signal amplitude declined more
markedly to ∼45% of baseline at 240 s and thereafter continued
to decline at a slower rate (Figure 3A). Figure 3B demonstrates
how this slower decline paralleled the linear optical signal ampli-
tude decline observed with time in control non-VF preparations.
This suggests that the continued slow reduction in optical signal
amplitude after 240 s results from reduction in the ﬂuorescence
signal with time. Indeed, correcting the optical signal amplitude
during control VF resulted in identical fractional changes to the
ECG amplitude (Figure 3C).
FIGURE 2 | Optical traces duringVF and assessment of coordination.
(A) Shows typical optical traces by the PDA during VF. (B) Shows overlaying
of six adjacent signals from the highlighted area. The signals are
superimposed with time off-set to allow maximum cross-correlation.
Spatiotemporally, the reduction in optical amplitude was not
homogeneous across the anterior surface of the heart (Figure 4A).
Rather, there was a more profound amplitude reduction in the
LV than the RV (Table 1). This LV/RV heterogeneity in amplitude
reduction was not observed in control non-VF preparations where
the fractional amplitude reduction was homogeneous across the
interrogated area (Figure 3D).
VF AMPLITUDE IN LOW-FLOW ISCHEMIA
In Figure 5A i and ii, the ECG and optical signal show similar pat-
terns of amplitude change in VF during the low-ﬂow ischemia
(n = 7). On reducing the ﬂow rate to 6ml/min, there was an
immediate increase in the amplitude which reached a peak at
120 s (black arrows in Figure 5A). After this peak, both ampli-
tudes decreased in a near linear fashion until the protocol end at
600 s with amplitude reductions to ∼33%. From previous work
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FIGURE 3 | Change in ECG and optical signal amplitude in control
conditions and effect of signal degradation on optical signal
amplitude. (A) Plot of fractional change in ECG and optical signal
amplitude with time in control perfused VF. (B) Plot of change in optical
signal amplitude with time during atrial pacing and during VF in control
conditions. (C) Plot of amplitude changes in ECG and corrected optical
signal in control conditions. (D) Color map of the fractional change in
amplitude during RA pacing after 480 s.
this peak coincides with the dramatic fall in DF to a steady-
state that occurs immediately on ﬂow reduction (Caldwell et al.,
2007).
In low-ﬂow ischemia, the spatiotemporal distribution of
the fractional amplitude changes at 480 s was not signiﬁcantly
different from control, although there was a tendency for a greater
reduction in RV optical amplitude (Figure 4B, Table 1).
VF AMPLITUDE IN RAISED [K+]O
During VF in raised [K+]o (n = 5) the fractional change in ECG
amplitude initially decreased to a trough at 210 s of 0.77± 0.09
in 8mM [K+]o (Figure 5Bi). This was not signiﬁcantly different
from the fractional change of 0.62± 0.05 in control conditions at
the same time point. After the trough, there was a steady increase
in ECG amplitude so that by the 420–540 s observation period the
fractional change in 8mM [K+]o was 1.05± 0.13**.
FIGURE 4 | Color-coded maps of fractional change in optical signal
amplitude duringVF at 480 s. (White dotted lines=LV/RV boundary, white
squares= standardized areas to determine ventricular optical amplitude).
(A) Fractional change under control conditions (perfused) (B) during low
ﬂow ischaemia (C) during perfusion with 8mM K.
Over the same period the fractional change in optical sig-
nal amplitude increased to 0.78± 0.09*** in 8mM [K+]o
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Table 1 | Change in signal amplitude duringVF in LV and RV expressed
as a percentage of the baseline amplitude.
Amplitude (% of baseline) Control Low-flow 8mM K+
LV PC 33±5** 32±3 60±15
RV PC 63±8** 49±9 100±15
**p<0.01.
(***p< 0.001 c.f. control of 0.37± 0.04; Figure 5Bii). In raised
[K+]o, the spatiotemporal amplitude alterations were also dif-
ferent from that observed during VF in control conditions
(Table 1, Figure 4C). At 480 s, the RV amplitude is maintained
in 8mM [K+]o.
EPICARDIAL TRANSMEMBRANE POTENTIAL IN VF
Figure 1Di shows a typical transmembrane potential recorded
with a ﬂoating microelectrode on the LV epicardial surface of a
Langendorff-perfused rabbit heart during VF induction. As pre-
viously reported (Caldwell et al., 2007) the averaged signals of
membrane potential from the epicardial surface of the LV revealed
a similar DF progression to those of ECG and psECG under con-
trol conditions, low-ﬂow ischemia and 8mM [K+] (Figure 6A).
Figure 6B shows that under control conditions, the maximum
systolic membrane potential decreased in VF compared to imme-
diately post VF induction values (initial VF, −9± 5mV; VF
420–540 s, −24± 6mV, p< 0.05) whilst the diastolic membrane
potential remained stable (initial VF, −61± 2mV; VF 420–540 s,
−65± 3mV) resulting in an amplitude reduction to 79% com-
pared to theVF amplitude immediately after induction. Figure 6C
shows that the systolic and diastolic membrane potentials during
low-ﬂow ischemia were not signiﬁcantly different from control.
Perfusion with 8mM [K+]o during VF tended to depolarized
the diastolic membrane potential (control VF, −65± 3mV; 8mM
[K+] VF, −59± 5mV) and resulted in an amplitude reduction to
93% compared to that immediately after induction (Figure 6D).
CROSS-CORRELATION OF OPTICAL SIGNALS
Figure 7 shows the progression of mean correlation coefﬁcient
across the optical ﬁeldwith time. In control conditions thedecreas-
ing organization is reﬂected in a fall in the mean correlation coef-
ﬁcient from at 0.36± 0.02 to 0.28± 0.003 at 600 s (p< 0.01). By
comparison, the level of coordination was relatively constant over
time in low-ﬂow ischemia with the correlation coefﬁcient at base-
line of 0.41± 0.03 not signiﬁcantly different from 0.37± 0.005
at 600 s. In contrast, at [K+]o = 8mM, the local signals became
more co-ordinated as VF progressed and the correlation coefﬁ-
cient increased from 0.36± 0.02 at baseline to 0.53± 0.08 at 600s
(p< 0.05).
CONDUCTION VELOCITY AND OPTICAL SIGNAL AMPLITUDE
Figure 8 uses sample recordings from ﬂoating microelectrodes to
illustrate the effect of the change in shape of the action potential
and slowing of conduction velocity on the optical signal averaged
across a pixel. Dimensions of pixel and conduction velocity are
based on measurement system and conduction velocity obtained
during the study. Shorter duration APs and slower conduction
velocity results in a greater change in the optical signals compared
to the transmembrane signals from which they are derived.
DISCUSSION
The aim of this to study was to examine the contribution of
reduced spatial organization and reduction in cellular action
potential (AP) amplitude to the global and spatiotemporal ampli-
tude changes during VF. This study is the ﬁrst to document a
decline in ECG and LV optical VF amplitude in fully perfused VF
and to show that this is not solely due to reduced AP amplitude at
a cellular level. We hypothesize that the remainder of the ampli-
tude reduction is due to decreased inter-cellular coordination and
supply evidence that supports this conjecture. This study is also
the ﬁrst to show an apparent increase in ECG and LV optical VF
amplitude with time in raised [K+]o and that we hypothesize is
solely due to increased inter-cellular electrical coordination as the
AP amplitude was actually reduced.
VF AMPLITUDE IN CONTROL CONDITIONS
In VF during fully perfused control conditions, the amplitude of
the ECG decreased in a non-linear fashion. An initial period of
rapid amplitude reduction was followed stabilization at ∼55%.
The ECG gives a global assessment of the electrical activity of the
heart, and as such a reduction in its amplitude could represent (i)
a homogeneous decrease in the amplitude of the electrical activa-
tions across the heart, (ii) heterogeneous changes, or (iii) no real
decrease in the amplitude of the electrical activations, but rather
an increase in electrical disorganization, as is known to occur in
fully perfusedVF (Witkowski et al., 1998).With increased disorga-
nization, the local electrical vectors will increasingly oppose each
other, thereby reducing the electrical amplitude as measured at a
global level.
Although the optically derived psECG is also a global mea-
sure of electrical activity, its amplitude change is derived from
the amplitude changes recorded in each of the 252 photodi-
odes. As each photodiode records from a small epicardial area
(0.8mm× 0.8mm), vector alignment does not inﬂuence optical
signal amplitude. However the amplitude of the optical signal may
still be inﬂuenced by the reduction of inter-cellular synchrony.
In optical mapping, the signal from a single pixel represents the
summated activity from several thousands of cells (Bishop et al.,
2009). As the AP propagates across the ∼1mm2 of epicardium
recorded by the photodiode, there is a delay in the activation time
of each cell and hence the upstroke of the optical AP is slower than
the simultaneous transmembrane AP (Figure 1). During regular
pacing in control conditions, the average conduction velocity of
∼50 cm/s (Wiegerinck et al., 2006; Caldwell et al., 2007) creates
a 2ms spread of activation times across the pixel. Although this
spread of activation acts to reduce the upstroke velocity, it does
not signiﬁcantly affect the AP amplitude due to the AP plateau,
i.e., the plateau phase of the AP allows synchronization of the
equivalent ﬂuorescence phase in the hundreds of cells within the
pixel (Figure 8A). In contrast, in VF the AP duration is dramat-
ically curtailed and the AP morphology altered such that there
is no prolonged plateau phase [Figure 8Bi]. Such changes allow
little time for synchronization of the peak ﬂuorescence between
cells. Also during VF the conduction velocity is reduced creating a
greater spread of activation times across the pixel. So theoretically,
a change in the local synchrony of activation could also affect the
optical amplitude.
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FIGURE 5 | Amplitude changes duringVF. (A) Shows the fractional
amplitude changes that occurred in control (n =7) and low-ﬂow ischemia
(n =7). (A) (i) Changes in ECG amplitude with time. (A) (ii) Changes in optical
signal amplitude with time after correction for optical signal degradation. (B)
Shows the ECG and optical signal amplitude during VF in 8mM (n =6) and
10mM (n =5) [K+] solutions. (B) (i) Changes in ECG amplitude with time
(**p<0.01). (B) (ii) Changes in optical signal amplitude with time
(***p<0.001). (All optical data corrected for signal degradation.)
Transmembrane recordings during VF in control conditions
showed that the amplitude reduction was due to reduced sys-
tolic depolarization. However the reduction of AP amplitude to
79% of that immediately post VF induction was considerably less
than the AP amplitude reduction measured by ECG (57% of that
immediately post VF induction) or optically (54% of the ampli-
tude immediately post VF induction after correction for signal
degradation). So although the AP amplitude is reduced at the
cellular level, this cannot explain all the amplitude reduction of
ECG and optical recordings. The reduction in mean correlation
coefﬁcient with time in perfused VF show decreased coordination
between groups of cells within adjacent pixels and thus suggests
reduced inter-cellular coordination with time. The greater coordi-
nation seen within the low-ﬂow group may be linked to the higher
extracellular K+ levels during ischemia, since K+ alone increases
the mean correlation coefﬁcient.
VF AMPLITUDE IN LOW-FLOW ISCHEMIA
Both clinical (Weaver et al., 1985; Strohmenger et al., 1997, 2001;
Eftestol et al., 2004) and animal studies (Brown et al., 1989; Noc
et al., 1994; Strohmenger et al., 1996; Achleitner et al., 2000, 2001;
Kolarova et al., 2003) show reduction of ECG amplitude during
VF with time when cardiac perfusion is not maintained. Similarly,
this study demonstrated reductions of ECG and optical signal
amplitudes in VF during low-ﬂow ischemia. However, on reduc-
ing perfusion, the ECG and optical signal amplitude transiently
increased. Two possible explanations for this transient amplitude
increase are: – (i) Hyperpolarization – low levels of intracellular
Frontiers in Physiology | Cardiac Electrophysiology May 2012 | Volume 3 | Article 147 | 6
Caldwell et al. Signal amplitude in VF
FIGURE 6 | Results from epicardial transmembrane recordings from
the LV duringVF. (A) Microelectrode DF during VF. (B) Membrane
potential during VF in control conditions. (C) Membrane potential during
during VF in low-ﬂow ischemia. (D) Membrane potential during VF in 8mM
[K+] solution. (Gray bar highlights time interval of 420–540 s used for
statistical comparison).
FIGURE 7 | Plot of mean correlation coefficient across the optical field
with time.The correlation coefﬁcient is seen to fall with time in control
conditions, to be conserved in low-ﬂow ischemia and to increase with time
in [K+]o 8mM.
acidosis are known to hyperpolarize the resting membrane poten-
tial (Sato et al., 1985) and so may increase the VF AP amplitude.
In ischemia, the myocardial pH decreases exponentially with time
(Garlick et al., 1979). Thus any hyperpolarization would be tran-
sient, as the pH fell further to levels known to depolarize the resting
membrane potential (Sato et al., 1985). This is unlikely to be the
explanation as the effect is probably quite small and if anything
there is diastolic depolarization as seen in Figure 6Cii. Increased
electrical coordination – in global ischemia,VF becomes more co-
ordinated (Wiggers, 1940; Mandapati et al., 1998; Rogers et al.,
1999; Huang et al., 2004). Such coordination may cause an appar-
ent increase in VF amplitude. In contrast to the ECG and optical
signal amplitudes, and in keeping with previous research (Czar-
necka et al., 1973; Kleber, 1983), transmembrane recordings did
not demonstrate transient increases inVF amplitude on reduction
of perfusion rate. This suggests that the transient increase in ECG
and optical signal amplitudes were secondary to increased elec-
trical coordination. Examination of mean correlation coefﬁcient
tends to support this argument as it remained constant during VF
in low-ﬂow ischemia and did not decrease as seen in controlled
conditions.
VF AMPLITUDE IN RAISED [K+]O
In this study the ECG and optical signal amplitude initially
decreased during VF in raised [K+]o and then increased. This
secondary amplitude augmentation runs contrary to theoretical
expectations and previous experimental ﬁndings. Theoretically,
raising [K+]o from 5.5 to 11mM depolarizes the resting mem-
brane potential from −82 to −64mV, whilst experimentally in
whole heart (Kleber, 1983; Wilde, 1988) and cellular prepara-
tions (Tissier et al., 2002), raising [K+]o to 11mM depolarizes the
membrane by∼26mV and reduces the AP amplitude accordingly
(Kleber, 1983; Tissier et al., 2002). As above another consideration
in optical recordings is the APD, as the longer the plateau phase
the higher the chance of peak amplitude coordination, and thus
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FIGURE 8 | Illustration of earliest and latest activation within a single
pixel in regular pacing andVF and the effect on resultant optical
signal. (A) During regular pacing. (i) transmembrane AP – assuming
CV=50 cm/s across the ∼1mm2 pixel, the maximal delay between the
ﬁrst and last activation would be ∼2ms. (ii) Resultant optical signal from a
single pixel. (B) During VF. (i) transmembrane AP – with greatly reduced
APD.The reduced CV of∼35 cm/s increases the maximal delay to∼3.5ms.
(ii) Resultant optical signal from a single pixel.
the greater the peak optical amplitude. Previous studies, including
our own, document reduced APD in raised [K+]o, a phenomenon
that would tend to reduce rather than increase optical amplitude
(Koller et al., 2000; Caldwell et al., 2007).
The observed increase in VF amplitude coincides with a reduc-
tion in ECG, psECG, and LV DF (Caldwell et al., 2007). This
suggests that as the frequency of the activations decreases, the
electrical activity in VF becomes more organized, and hence the
amplitude of the global ECG measurements increases as the local
electrical vectors reinforce each other. Such increased organization
is not associatedwith increases inAP amplitude at the cellular level
as shown by transmembrane recordings. Rather microelectrode
studies demonstrated signiﬁcant depolarization of the diastolic
membrane potential during VF in raised [K+]o and reduction of
the AP amplitude to 93% of baseline consistent with theoreti-
cal predictions and previous studies (Kleber, 1983; Tissier et al.,
2002). One possible explanation for increased coordination in VF
in raised [K+]o is reduced conduction velocity which has been
previously described (Koller et al., 2000). However, as previously
published, there was no signiﬁcant change in conduction velocity
in raised [K+]o in the conditions used in this study (Caldwell et al.,
2007).
In this study we conﬁrmed increased electrical coordination
with time during VF in raised [K+]o by demonstrating that the
optical correlation coefﬁcient also increased with time. As stated
before although this coefﬁcient represents coordination between
adjacent groups of cells within each pixel we believe it is a true
reﬂection of the electrical coordination at the cellular level.
STUDY LIMITATIONS
The use of optical mapping to assess myocardial electrical acti-
vation means that the data is inherently limited to the ﬁrst
few nanometers of the epicardial surface. Previous studies using
plunge needles have suggested that asVF progresses changes in the
epicardium are slower than changes in the endocardium (New-
ton et al., 2004). However such plunge needles interfere with
the micro-structure of the heart and affect the electrical changes.
The similar frequency and amplitude changes that occurred in
the global ECG and optical measurements in this study suggest
that the epicardial changes are a reasonable reﬂection of the whole
myocardium.Opticalmapping has been performed in rabbit heart
wedge preparations but here the heart is too small to sustain VF.
Whilst it could be argued that “no ﬂow” ischemia is more clini-
cally relevant than “low-ﬂow,” we found that in no ﬂow the heart
quickly spontaneously converted to a regular organized rhythm of
ventricular origin (idioventricular escape-like rhythm). Such con-
versions are only rarely reported in humans. The ﬂow rates used
in“low-ﬂow”are akin to the perfusion achieved in CPR (i.e., 25%)
and thus do have a clinical correlate.
CONCLUSION
This study documents for the ﬁrst time that during VF in con-
trol conditions ECG activation amplitude reduces with time. This
amplitude decline is due to a combination decreased systolic acti-
vation at the cellular level and increased disorganization of the
electrical activity. This study also shows that during VF, ECG, and
optical mapping may show increases in amplitude as a result of
increased electrical synchrony. The complexity of this relation-
ship suggests that amplitude will not be a useful marker of VF
progression in clinical scenarios.
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